SCHEMBL30385183

SCHEMBL30385183

Clc1ccc(-c2nnc(-c3ccc4nc(-c5c(Cl)cccc5Cl)[nH]c4c3)o2)cc1

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
DGAT1 O75907 5/20 1.00
GUSB P08236 7/20 0.58
EGFR P00533 3/20 0.50
ERBB2 P04626 2/20 0.50
KDM4E B2RXH2 4/20 0.47
ALDH1A1 P00352 3/20 0.47
TP53 P04637 3/20 0.47
HSD17B10 Q99714 3/20 0.47
NPC1 O15118 2/20 0.47
NFKB1 P19838 2/20 0.47
RAB9A P51151 2/20 0.47
NFKB2 Q00653 2/20 0.47
RELA Q04206 2/20 0.47
MEN1 O00255 2/20 0.47
MAPT P10636 2/20 0.47
HPGD P15428 2/20 0.47
KMT2A Q03164 2/20 0.47
APP P05067 1/20 0.47
GAA P10253 1/20 0.47
SNCA P37840 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1252088 1.00 DGAT1 (1.00) DGAT1GUSBEGFRERBB2KDM4E
SCHEMBL13881979 0.93 DGAT1 (0.86) DGAT1GUSB
SCHEMBL1251902 0.91 DGAT1 (0.83) DGAT1GUSBEGFRKDM4ETP53
SCHEMBL1251954 0.91 DGAT1 (0.83) DGAT1GUSBALDH1A1NPC1RAB9A
SCHEMBL1251973 0.91 DGAT1 (0.83) DGAT1GUSBKDM4EALDH1A1HSD17B10
SCHEMBL30385827 0.89 DGAT1 (0.80) DGAT1GUSBEGFRERBB2KDM4E
SCHEMBL1252711 0.89 DGAT1 (0.80) DGAT1GUSBEGFRERBB2KDM4E
SCHEMBL1252695 0.89 DGAT1 (0.79) DGAT1GUSB
SCHEMBL1252721 0.88 DGAT1 (0.79) DGAT1GUSBEGFRERBB2KDM4E
SCHEMBL1250498 0.88 DGAT1 (1.00) DGAT1GUSBEGFRERBB2KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-113166204-B Cyclic peptides as inhibitors of proprotein convertase subtilisin/kexin type 9 (PCSK 9) for the treatment of metabolic disorders 诺华股份有限公司 2025-01-28 CN disclosed
CN-113166114-B Cyclic tetramer compounds as inhibitors of proprotein convertase subtilisin/KEXIN type 9 (PCSK 9) for the treatment of metabolic disorders 诺华股份有限公司 2025-01-03 CN disclosed
WO-2023084449-A1 DIAMINOCYCLOPENTYLPYRIDINE DERIVATIVES FOR THE TREATMENT OF A DISEASE OR DISORDER NOVARTIS AG (CH) 2023-05-19 WO disclosed